Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 521

Similar articles for PubMed (Select 15545326)

1.

In-vivo imaging of Alzheimer disease beta-amyloid with [11C]SB-13 PET.

Verhoeff NP, Wilson AA, Takeshita S, Trop L, Hussey D, Singh K, Kung HF, Kung MP, Houle S.

Am J Geriatr Psychiatry. 2004 Nov-Dec;12(6):584-95.

PMID:
15545326
2.

PET imaging of brain with the beta-amyloid probe, [11C]6-OH-BTA-1, in a transgenic mouse model of Alzheimer's disease.

Toyama H, Ye D, Ichise M, Liow JS, Cai L, Jacobowitz D, Musachio JL, Hong J, Crescenzo M, Tipre D, Lu JQ, Zoghbi S, Vines DC, Seidel J, Katada K, Green MV, Pike VW, Cohen RM, Innis RB.

Eur J Nucl Med Mol Imaging. 2005 May;32(5):593-600. Epub 2005 Mar 25.

PMID:
15791432
3.

Assessment of beta-amyloid in a frontal cortical brain biopsy specimen and by positron emission tomography with carbon 11-labeled Pittsburgh Compound B.

Leinonen V, Alafuzoff I, Aalto S, Suotunen T, Savolainen S, Någren K, Tapiola T, Pirttilä T, Rinne J, Jääskeläinen JE, Soininen H, Rinne JO.

Arch Neurol. 2008 Oct;65(10):1304-9. doi: 10.1001/archneur.65.10.noc80013. Epub 2008 Aug 11.

PMID:
18695050
4.

Development of a PET/SPECT agent for amyloid imaging in Alzheimer's disease.

Wang Y, Klunk WE, Debnath ML, Huang GF, Holt DP, Shao L, Mathis CA.

J Mol Neurosci. 2004;24(1):55-62.

PMID:
15314250
5.

Voxel-based analysis of Alzheimer's disease PET imaging using a triplet of radiotracers: PIB, FDDNP, and FDG.

Shin J, Lee SY, Kim SJ, Kim SH, Cho SJ, Kim YB.

Neuroimage. 2010 Aug 15;52(2):488-96. doi: 10.1016/j.neuroimage.2010.04.013. Epub 2010 Apr 10.

PMID:
20385246
6.

Carbon 11-labeled pittsburgh compound B positron emission tomographic amyloid imaging in patients with APP locus duplication.

Remes AM, Laru L, Tuominen H, Aalto S, Kemppainen N, Mononen H, Någren K, Parkkola R, Rinne JO.

Arch Neurol. 2008 Apr;65(4):540-4. doi: 10.1001/archneur.65.4.540.

PMID:
18413480
7.

PET amyloid ligand [11C]PIB uptake is increased in mild cognitive impairment.

Kemppainen NM, Aalto S, Wilson IA, Någren K, Helin S, Brück A, Oikonen V, Kailajärvi M, Scheinin M, Viitanen M, Parkkola R, Rinne JO.

Neurology. 2007 May 8;68(19):1603-6.

PMID:
17485647
8.

Voxel-based analysis of PET amyloid ligand [11C]PIB uptake in Alzheimer disease.

Kemppainen NM, Aalto S, Wilson IA, Någren K, Helin S, Brück A, Oikonen V, Kailajärvi M, Scheinin M, Viitanen M, Parkkola R, Rinne JO.

Neurology. 2006 Nov 14;67(9):1575-80. Epub 2006 Sep 13.

PMID:
16971697
9.

Evaluation of voxel-based methods for the statistical analysis of PIB PET amyloid imaging studies in Alzheimer's disease.

Ziolko SK, Weissfeld LA, Klunk WE, Mathis CA, Hoge JA, Lopresti BJ, DeKosky ST, Price JC.

Neuroimage. 2006 Oct 15;33(1):94-102. Epub 2006 Aug 14.

PMID:
16905334
10.

Radiation dosimetry of beta-amyloid tracers 11C-PiB and 18F-BAY94-9172.

O'Keefe GJ, Saunder TH, Ng S, Ackerman U, Tochon-Danguy HJ, Chan JG, Gong S, Dyrks T, Lindemann S, Holl G, Dinkelborg L, Villemagne V, Rowe CC.

J Nucl Med. 2009 Feb;50(2):309-15. doi: 10.2967/jnumed.108.055756. Epub 2009 Jan 21.

11.

Biological characters of [18F]O-FEt-PIB in a rat model of Alzheimer's disease using micro-PET imaging.

Zheng MQ, Yin DZ, Zhang L, Lei B, Cheng DF, Cai HC, Han YJ, Wu MX, Zhang H, Wang J.

Acta Pharmacol Sin. 2008 May;29(5):548-54. doi: 10.1111/j.1745-7254.2008.00785.x.

12.

Reproducibility of automated simplified voxel-based analysis of PET amyloid ligand [11C]PIB uptake using 30-min scanning data.

Aalto S, Scheinin NM, Kemppainen NM, Någren K, Kailajärvi M, Leinonen M, Scheinin M, Rinne JO.

Eur J Nucl Med Mol Imaging. 2009 Oct;36(10):1651-60. doi: 10.1007/s00259-009-1174-1. Epub 2009 Jun 4.

PMID:
19495749
13.

Longitudinal, quantitative assessment of amyloid, neuroinflammation, and anti-amyloid treatment in a living mouse model of Alzheimer's disease enabled by positron emission tomography.

Maeda J, Ji B, Irie T, Tomiyama T, Maruyama M, Okauchi T, Staufenbiel M, Iwata N, Ono M, Saido TC, Suzuki K, Mori H, Higuchi M, Suhara T.

J Neurosci. 2007 Oct 10;27(41):10957-68.

14.

Effect of APOE genotype on amyloid plaque load and gray matter volume in Alzheimer disease.

Drzezga A, Grimmer T, Henriksen G, Mühlau M, Perneczky R, Miederer I, Praus C, Sorg C, Wohlschläger A, Riemenschneider M, Wester HJ, Foerstl H, Schwaiger M, Kurz A.

Neurology. 2009 Apr 28;72(17):1487-94. doi: 10.1212/WNL.0b013e3181a2e8d0. Epub 2009 Apr 1.

PMID:
19339712
15.

Amyloid PET in mild cognitive impairment and Alzheimer's disease with BF-227: comparison to FDG-PET.

Furukawa K, Okamura N, Tashiro M, Waragai M, Furumoto S, Iwata R, Yanai K, Kudo Y, Arai H.

J Neurol. 2010 May;257(5):721-7. doi: 10.1007/s00415-009-5396-8. Epub 2009 Nov 28.

PMID:
19946781
16.

Multitracer PET imaging of amyloid plaques and neurofibrillary tangles in Alzheimer's disease.

Shin J, Lee SY, Kim SH, Kim YB, Cho SJ.

Neuroimage. 2008 Nov 1;43(2):236-44. doi: 10.1016/j.neuroimage.2008.07.022. Epub 2008 Jul 23.

PMID:
18694837
17.

Beta-amyloid burden in the temporal neocortex is related to hippocampal atrophy in elderly subjects without dementia.

Bourgeat P, Chételat G, Villemagne VL, Fripp J, Raniga P, Pike K, Acosta O, Szoeke C, Ourselin S, Ames D, Ellis KA, Martins RN, Masters CL, Rowe CC, Salvado O; AIBL Research Group.

Neurology. 2010 Jan 12;74(2):121-7. doi: 10.1212/WNL.0b013e3181c918b5.

PMID:
20065247
18.

Positron emission tomography radiopharmaceuticals for imaging brain Beta-amyloid.

Vallabhajosula S.

Semin Nucl Med. 2011 Jul;41(4):283-99. doi: 10.1053/j.semnuclmed.2011.02.005. Review.

PMID:
21624562
19.

[Molecular imaging of beta-amyloid plaques in the brain].

Ono M.

Brain Nerve. 2007 Mar;59(3):233-40. Review. Japanese.

PMID:
17370649
20.

Visual assessment versus quantitative assessment of 11C-PIB PET and 18F-FDG PET for detection of Alzheimer's disease.

Ng S, Villemagne VL, Berlangieri S, Lee ST, Cherk M, Gong SJ, Ackermann U, Saunder T, Tochon-Danguy H, Jones G, Smith C, O'Keefe G, Masters CL, Rowe CC.

J Nucl Med. 2007 Apr;48(4):547-52.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk